Avanos Medical, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 173.3 million compared to USD 181.6 million a year ago. Net income was USD 10.5 million compared to USD 16.9 million a year ago. Basic earnings per share from continuing operations was USD 0.24 compared to USD 0.21 a year ago. Diluted earnings per share from continuing operations was USD 0.24 compared to USD 0.21 a year ago. Basic earnings per share was USD 0.23 compared to USD 0.36 a year ago. Diluted earnings per share was USD 0.23 compared to USD 0.36 a year ago.
For the full year, sales was USD 673.3 million compared to USD 684.1 million a year ago. Net loss was USD 61.8 million compared to net income of USD 50.5 million a year ago. Basic loss per share from continuing operations was USD 0.21 compared to basic earnings per share from continuing operations of USD 0.46 a year ago. Diluted loss per share from continuing operations was USD 0.21 compared to diluted earnings per share from continuing operations of USD 0.46 a year ago. Basic loss per share was USD 1.32 compared to basic earnings per share of USD 1.08 a year ago. Diluted loss per share was USD 1.32 compared to diluted earnings per share of USD 1.07 a year ago.